2432.HK 9885.HK

Robot manufacturer Shenzhen Dobot Corp. Ltd. (2432.HK) on Tuesday announced a strategic collaboration with YSB Inc. (9885.HK) to jointly develop robots for pharmaceutical applications. The partnership will see Dobot spearhead product development, as well as post-sales maintenance. YSB will validate application scenarios, facilitate operational integration, and lead marketing and sales efforts for the co-developed robots.

Both parties have already finalized a plan for their first project, including completion of a feasibility study, technical route research and judgement, exchange of technical solutions, and selection of suitable deployment environment, and have begun to build a test platform.

Founded in 2015, Dobot develops and manufactures collaborative robots, with a portfolio of over 20 products. YSB, established the same year, provides digital and smart solutions for independent pharmacies, drugstore chains, and primary care institutions.

Shares of Dobot opened up 1.7% at HK$58.90 on Wednesday and continued to rise during the session to close up 7.4% at the midday break. YSB shares opened up 7% at HK$10.76, but gave back most of the gains to close up 0.8% by the midday break.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Ele.me get rolled into Alibaba's e-commerce

Alibaba turns up its ‘instant retail’ game

The merger of its Ele.me service with its core e-commerce business marks a new stage in the e-commerce giant’s three-way “on-demand retail wars” with Meituan and JD.com Key Takeaways: Alibaba…